Retinal toxic effects following inadvertent intraocular injection of Celestone Soluspan.
Pendergast
S D
SD
Eliott
D
D
Machemer
R
R
D001284:Atrophy; D001623:Betamethasone / Q000009:adverse effects / Q000031:analogs & derivatives*; D001993:Bronchodilator Agents / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D005260:Female; D005355:Fibrosis; D005654:Fundus Oculi; D006801:Humans; D007267:Injections; D007910:Lenses, Intraocular; D008028:Light Coagulation; D008875:Middle Aged; D018918:Phacoemulsification; D012160:Retina / Q000187:drug effects* / Q000473:pathology / Q000601:surgery; D012163:Retinal Detachment / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D012167:Retinal Perforations / Q000139:chemically induced / Q000473:pathology; D013536:Suture Techniques; D014792:Visual Acuity; D014821:Vitrectomy
D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; C018230:betamethasone acetate phosphate; D001623:Betamethasone